Previous Article | Next Article 
Journal of Clinical Microbiology, November 2001, p. 4086-4092, Vol. 39, No. 11
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.4086-4092.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Clinical and Environmental Isolates of Vibrio
cholerae Serogroup O141 Carry the CTX Phage and the Genes
Encoding the Toxin-Coregulated Pili
A.
Dalsgaard,1,*
O.
Serichantalergs,2
A.
Forslund,1
W.
Lin,3
J.
Mekalanos,3
E.
Mintz,4
T.
Shimada,5 and
J.
G.
Wells4
Department of Veterinary Microbiology, Royal Veterinary and
Agricultural University, Frederiksberg, DK-1870 Frederiksberg C,
Denmark1; Armed Forces Research
Institute of Medical Sciences, Bangkok 10400, Thailand2; Department of Microbiology
and Molecular Genetics, Harvard Medical School, Boston,
Massachusetts3; Foodborne and Diarrheal
Diseases Branch, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta,
Georgia4; and Department of
Bacteriology, National Institute of Infectious Diseases, Shinjuku-ku,
Tokyo 162-8640, Japan5
Received 26 April 2001/Returned for modification 29 July
2001/Accepted 2 September 2001
 |
ABSTRACT |
We report sporadic cases of a severe gastroenteritis associated
with Vibrio cholerae serogroup O141. Like O1 and O139
serogroup strains of V. cholerae isolated from cholera
cases, the O141 clinical isolates carry DNA sequences that hybridize to
cholera toxin (CT) gene probes. The CT genes of O1 and O139 strains are
carried by a filamentous bacteriophage (termed CTX phage) which is
known to use toxin-coregulated pili (TCP) as its receptor. In an effort to understand the mechanism of emergence of toxigenic O141 V. cholerae, we probed a collection of O141 clinical and
environmental isolates for genes involved in TCP production,
toxigenicity, virulence regulation, and other phylogenetic
markers. The collection included strains isolated between 1964 and 1995 from diverse geographical locations, including eight countries and five
U.S. states. Information collected about the clinical and environmental
sources of these isolates suggests that they had no
epidemiological association. All clinical O141 isolates
hybridized to probes specific for genes encoding CT
(ctx), zonula occludens toxin (zot),
repetitive sequence 1 (RS1), RTX toxin (rtxA), the major
subunit of TCP (tcpA), and the essential regulatory gene
that controls expression of both CT and TCP (toxR). In
contrast, all but one of the nonclinical O141 isolates were negative
for ctx, zot, RS1, and
tcpA, although these strains were positive for
rtxA and toxR. The one toxigenic environmental O141 isolate was also positive for tcpA.
Ribotyping and CT typing showed that the O141 clinical isolates were
indistinguishable or closely related, while a toxigenic water isolate
from Louisiana showed a distantly related ribotype. Nonclinical
O141 isolates displayed a variety of unrelated ribotypes. These data
support a model for emergence of toxigenic O141 that involves
acquisition of the CTX phage sometime after these strains had acquired
the pathogenicity island encoding TCP. The clonal nature of
toxigenic O141 strains isolated from diverse geographical locations
suggests that the emergence is a rare event but that once it occurs,
toxigenic O141 strains are capable of regional and perhaps even global
dissemination. This study stresses the importance of monitoring
V. cholerae non-O1, non-O139 serogroup strains for their
virulence gene content as a means of assessing their epidemic potential.
 |
INTRODUCTION |
The two most important virulence
factors of Vibrio cholerae are cholera toxin (CT), a potent
enterotoxin, and the toxin-coregulated pilus antigen (TCP), an
essential intestinal colonization factor (16). These
virulence factors are encoded by accessory genetic elements which are
nearly always present in clinical isolates of V. cholerae
but are frequently absent in strains isolated from environmental
sources, such as water or shellfish (6, 16, 17). The
ctxAB genes are located on the CTX genetic element, which is
composed of a 4.5-kb central core region flanked by one or more copies
of a repetitive sequence (RS1 or RS2) (34). The core and
RS2, a portion of the CTX element, are now known to correspond to the
genome of a filamentous bacteriophage (designated CTX phage) (44). An essential CTX phage assembly gene called
zot has also been reported to encode a biological activity
called zonula occludens toxin (2, 44). The CTX phage uses
TCP as its receptor for infecting V. cholerae cells
(44). Once infection has occurred, CTX phage DNA can
either integrate into the chromosome via a specific attachment site
(attRS), forming stable lysogens, or replicate extrachromosomally as a plasmid (17, 44). The expression
of both ctx and tcp genes is regulated
coordinately by ToxR and other transcriptional regulatory genes in a
complicated network that continues to be intensively studied
(16).
TCP is encoded by chromosomal DNA that is present in pathogenic strains
and absent in most nonpathogenic strains of V. cholerae (25). This element has been referred to as the TCP
pathogenicity island (37) as well as the V. cholerae pathogenicity island (VPI) (23) because it
encodes several other virulence genes (25). A recent
report also suggested that the TCP pathogenicity island may correspond
to the genome of another filamentous bacteriophage, termed VPI phage
(24). The horizontal acquisition of the pathogenicity island encoding TCP has been proposed as a likely prerequisite for the
acquisition of CTX phage and thus for the emergence of new toxigenic
strains of V. cholerae with human colonization properties (44).
Support for this model for emergence of toxigenic V. cholerae comes from the characterization of environmental and
clinical non-O1, non-O139 strains. Non-O1 and non-O139 strains that are positive for CT but negative for TCP are exceedingly rare
(17). These observations have led to the proposal that
possession of tcp genes may be characteristic of the O1
serotypes (17). V. cholerae O139 strains are
TCP positive only because they emerged as O-antigen recombinants of a
CT- and TCP-positive El Tor O1 strain (17). However,
Echeverria et al. (15) demonstrated that V. cholerae serogroup O44, O49, and O8 strains isolated from flies in
northeastern Thailand in 1981 were positive for both CT and TCP genes.
Additionally, in a comparison of ribotypes and serogroups of clinical
V. cholerae non-O1, non-O139 isolates, Dalsgaard et al.
(9) noticed that strains of the O141 serogroup were
frequently CT positive, although the presence of other virulence genes
such as those encoding TCP was not assessed.
Although V. cholerae non-O1, non-O139 strains rarely contain
CT and TCP genes, they have been associated with sporadic cases of
gastroenteritis, including cholera-like diarrhea, mainly in tropical
areas (3, 8, 40). As the principal reservoir for V. cholerae is the aquatic environment, non-O1, non-O139 strains have
been isolated from surface waters in most parts of the world, including
North America. They are commonly isolated from shellfish, and most
cases of V. cholerae non-O1, non-O139 gastroenteritis acquired in the United States are associated with eating raw or undercooked oysters (30). However, the bacterial factors
responsible for the apparent pathogenicity of these CT-negative strains
have not been elucidated. Recently, the genomic sequence of V. cholerae has revealed the presence of a toxin gene cluster related
to the family of RTX toxins commonly produced by several different
pathogenic gram-negative bacteria (5). Lin et al.
(26) demonstrated that these genes encode a product that
is responsible for a cytotoxic activity observed when mammalian cells
are exposed to V. cholerae cells. Furthermore, the RTX
element was present in several environmental isolates of V. cholerae, including non-O1 and O1, CT-negative strains. These
results suggest that this toxin could be responsible for pathogenic
properties of non-O1 and non-O139 strains.
In the present study, we examined the virulence-associated gene content
of clinical and environmental isolates of V. cholerae O141.
 |
MATERIALS AND METHODS |
Patient information and bacteriology.
Information about
patients and V. cholerae strains isolated in the United
States was provided to the Centers for Disease Control and Prevention
(CDC), Atlanta, Ga., by physicians through health departments of
various states. In addition to the O141 strains isolated in the United
States, an additional three clinical and six environmental V. cholerae O141 strains received for serotyping at the National
Institute of Infectious Diseases, Tokyo, Japan, were included in the
study for comparison purposes. Strain designations and other
information are provided in Table 1.
All strains were identified biochemically as V. cholerae
non-O1 based on standard biochemical reactions (39) and
negative reactions in the agglutination tests employing polyvalent O1
antisera. The U.S. isolates were sent by the CDC to the National
Institute of Infectious Diseases for serotyping. It should be noted
that analyses of the files with the original strain information
revealed that the two environmental strains reported isolated in the
United States by Dalsgaard et al. (9) were identical.
Thus, only a single environmental V. cholerae O141 strain,
designated 3176-78, was isolated. Each of the V. cholerae
non-O1, non-O139 strains listed in Table 1 was examined serologically
by the slide agglutination test and designated according to an extended
serotyping system which contains more than 193 different O serotypes
(42; T. Shimada, personal communication). Preparation of O
antisera and slide agglutination were performed as previously described
(42). Although hybridization with CT and NAG-ST
(heat-stable enterotoxin) probes, serotyping, and ribotyping had been
done in a previous study (9), these characterization
techniques were repeated in the present study as described below.
Antibiotic susceptibility testing and isolation of plasmid
DNA.
Each isolate was tested for susceptibility to 12 antibacterial agents by the disk (Oxoid Ltd., Basingstoke, United
Kingdom) diffusion method using Mueller-Hinton agar (Difco, Detroit,
Mich.) as described by the National Committee for Clinical Laboratory Standards (31). The following antibiotics were used
(micrograms per disk): ampicillin, 30; chloramphenicol, 30;
ciprofloxacin, 5; colistin, 10; gentamicin, 10; kanamycin, 30;
nalidixic acid, 30; neomycin, 30; streptomycin, 10; sulfamethoxazole,
100; tetracycline, 30; and trimethoprim-sulfamethoxazole, 5.2/240.
Isolates were also tested for susceptibility to the vibriostatic agent
O/129 (2,4-diamino-6,7-diisopropylpteridine phosphate), 150 µg per disk.
Plasmid extraction was carried out using the method of Kado and Liu
(22), modified by incubating the cells at elevated pH (12.54) for 30 min at 56°C during the lysis step. V. cholerae O1 strain 1075/25 carrying a 150-kb plasmid was used as a
positive control (43). Electrophoresis and visualization
of plasmids were carried out essentially as previously described
(33).
DNA probes for detection of virulence-associated genes.
The
presence of several virulence-associated genes was determined through
hybridization with DNA probes. These genes included ctxA
(the A subunit of the CT gene), the NAG-ST gene, tcpA (the major subunit of the TCP gene), RS1 (the repetitive sequence
1 gene), zot (zonula occludens toxin gene), toxR
(an essential toxin-regulating gene), attRS1 (specific
attachment site 1 gene), CTXp (a CT phage gene),
pTLC (a toxin-linked cryptic plasmid gene), and
rtx (a RTX toxin gene) (Table
2). Although not specific for V. cholerae O141, the organization of the V. cholerae
chromosome, including pTLC, rtx, CTX phage, and
the CTX element, is shown in Fig. 1. Colony blots were prepared with nylon (Hybond; Amersham International plc, Aylesbury, United Kingdom) or Whatman filters and processed by
standards methods (21). Positive and negative V. cholerae control strains were included on all filters.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Genomic organization of the pTLC (TLC)
element, the CTX prophage, and the RTX gene cluster on the V.
cholerae chromosome. The pTLC element is 842 bp
upstream of the CTX element whereas the RTX gene cluster is 693 bp
downstream of the CTX element. Open and filled boxes represent ORFs
that are oriented left to right and right to left, respectively. The
pTLC element is tandemly duplicated on the chromosome. In El
Tor strains, the first copy contains an insertion sequence that shares
sequence similarity to IS911. The CTX prophage is also
commonly tandemly duplicated in toxigenic strains. In classical
strains, the RTX gene cluster is disrupted by a deletion that removes
part of rtxA and rtxB and all of
rtxC.
|
|
Ribotyping and CT genotyping.
The ribotypes of the V. cholerae O141 isolates were determined previously (9)
and established by using BglI to digest chromosomal DNA
(35). Ribotyping was performed by the procedure described by Dalsgaard et al. (7) with digoxigenin-labeled 16S and
23S rRNA probes. In our repeated ribotyping of the O141 strains,
V. cholerae O1 strains O70, 1083/30, and 2722/33
(11) and O139 strains ADC 1125/9 and NIH 178 (12) were included for comparison purposes. Restriction
fragment length polymorphism analysis of DNA sequences associated with
CT genes (CT genotyping) was performed by hybridization of nylon
membranes containing BglI-digested DNA with a
digoxigenin-labeled oligonucleotide CT probe (45). A 1-kb
DNA molecular size standard (GIBCO BRL, Gaithersburg, Md.) was used as
a size marker in ribotyping, and
/HindIII was used for CT genotyping. CT genotypes were determined for each of the nine
strains that hybridized with the CT probe. V. cholerae O1 strains 9868, isolated in Guinea-Bissau in 1996, and 1724/34, isolated
in Thailand in 1991 (11), were included in CT genotyping for comparison purposes. BglI was selected because it does
not have any recognition sequence within the ctxA gene but
it has a single cleavage site located upstream and adjacent to the
ctxA gene (29). Thus, the number of bands
comprising each CT genotype pattern represents the number of copies of
the ctxA harbored by each strain.
 |
RESULTS |
Patient information.
Limited epidemiologic and clinical
information accompanied the isolates sent to the CDC by the health
departments of various states (Table 1). All U.S. patients were adults,
ranging in age from 34 to 72 years old; three of the five patients were
men. The reported clinical diagnoses are shown in Table 1. No food or
travel histories were reported, with the exception of the patient from
California, who ate shellfish in Atlanta, Ga., before his illness
began. Four of the patients survived their illness; the outcome of the
remaining case from Maryland was not reported. Clinical details were
reported only for the patient from New York (diagnosis, cholera). This
previously healthy 55-year-old man presented to a New York City
hospital with complaints of malaise and diarrhea. He was passing
approximately 8 to 12 liters of rice water stool per day and had
indications of acute renal failure, including anuria and significant
metabolic acidosis. The patient responded well to hospitalization,
rehydration, and tetracycline treatment, with a gradual decrease in
diarrhea over a 1-week period. Information about patients and clinical
manifestations of the cases reported in Spain, Taiwan, and India
was not available (Table 1).
Biochemical reactions, antibiotic susceptibility patterns, and
plasmid analysis.
The V. cholerae non-O1 strains
produced yellow colonies on thiosulfate-citrate-bile
salt-sucrose agar and grew in NaCl concentrations of 0, 3, 6, and 7% but not 8%. All were oxidase and indole positive, fermented
glucose, produced lysine and ornithine decarboxylases but not arginine
dehydroxylase, and were ONPG
(o-nitrophenyl-
-D-galactopyranoside) positive. Only the three water isolates from Brazil utilized
cellobiose. All isolates were sensitive in susceptibility testing
to the vibriostatic agent O/129. The growth shown by the O141 strains
at relatively high salinities of 6 and 7% NaCl corroborates previous
findings with V. cholerae non-O1, non-O139
(10). Thus, strains showed biochemical reactions typical
of those of V. cholerae (31). Using the
extended serotyping scheme, the V. cholerae non-O1 strains agglutinated in O141 antisera in repeated testing (42).
Each of the strains tested showed resistance to colistin but were
sensitive to most of the remaining antibacterial agents tested,
including tetracycline, trimethoprim, chloramphenicol, and the
quinolones. V. cholerae non-O1 strains are normally
resistant to colistin. Strains 234-93 and 1178-96 showed resistance to
ampicillin. Plasmid analysis revealed that none of the clinical
isolates contained plasmids. Among the environmental isolates, strain
CH236, isolated from shrimp imported into Germany, contained plasmids
of 7.2 and 23 kb, and strain 574-94, isolated from water in Bolivia,
contained a single plasmid of 5.7 kb.
Virulence-associated genes.
The clinical and environmental
V. cholerae O141 were further characterized to provide
information about the presence of several genes which either encode
virulence factors or are genetically linked to virulence genes (i.e.,
virulence-associated genes) (Table 2). In the colony hybridization
studies, each of the clinical O141 strains and one strain isolated from
a Louisiana water sample contained sequences that hybridized to the
ctxA, RS1, and zot probes (Table
3). Since all three of the probes
hybridize to sequences located on CTX phage, these data strongly
suggest that all CT-positive O141 strains contain a copy of the CTX
prophage inserted in their chromosomes. This was corroborated by
hybridization of these strains with the CTXp probe. Inserted
upstream of CTX phage in El Tor O1 strains are two tandem copies of a
4.7-kbp cryptic plasmid termed pTLC (36). Evidence
suggests that this plasmid may stimulate the replication of CTX phage
in V. cholerae O1 El Tor strains (W. Lin and J. Mekalanos, unpublished results). All O141 strains were probed with a
pTLC probe, but all were negative (Table 3). This result
strongly suggests that O141 strains are not derived from toxigenic El
Tor O1 strains, a conclusion which is also supported by the ribotyping
data (see below).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Presence of virulence-associated genes among
V. cholerae 0141 strains isolated from
patients or environmental samples
|
|
All O141 strains tested hybridized with the toxR and
attRS1 gene probes, suggesting that environmental isolates
have the potential to integrate the CTX prophage and to regulate CT
expression (Table 3). However, all CT-negative environmental O141
strains lacked sequences that hybridized to tcpA, suggesting
that they are unlikely to serve as efficient recipients of CTX phage
(17, 44). Furthermore, all O141 strains tested, including
these TCP-negative environmental strains, were positive for the
rtx probe, suggesting that RTX toxin might be a virulence
factor produced by these environmental strains.
One environmental strain hybridized to the NAG-ST probe, a gene which
is known to exist on an integron-like genetic element in other strains
of V. cholerae (27).
Ribotyping and CT genotyping.
Examples of the different
V. cholerae O141 ribotypes are shown in Fig.
2 together with ribotypes of the O1 and
O139 strains. The clinical U.S. V. cholerae O141
strains 2454-85, 2466-85, and 2527-87 and the clinical reference
strain 234-93 from India showed an indistinguishable ribotype A (Fig.
2, lane I). The two remaining clinical U.S. strains, 609-84 and
2533-83, showed an indistinguishable ribotype B, which was very
closely related to type A, as the two types differed by a single
fragment only. The two ribotypes shown by the clinical U.S. strains
were also closely related to the indistinguishable ribotype C
demonstrated by the two clinical strains from Spain and Taiwan (Fig. 2
and Table 1). Each of the clinical O141 strains showed ribotypes which
differed from the types shown by O1 and O139 strains by two or more
fragments (Fig. 2).

View larger version (104K):
[in this window]
[in a new window]
|
FIG. 2.
Examples of BglI ribotypes of
V. cholerae O141 and serotype O1 and O139 reference
strains. Lanes (strain designation, O serogroup, and ribotype): B,
O79, O1, unnamed ribotype; C, 1083/30, O1, unnamed type; D, 2722/33,
O1, unnamed type; E, ADC 1125/9, O139, unnamed type; F, NIH 178, O139,
unnamed type; G, 3176-78, O141, ribotype E; H, 609-84, O141, type B; I,
2527-86, O141, type A; J, F2031, O141, type C; K, 574-94, O141, type D;
L, 930122, O141, type F; M, CH236, O141, type G; N, 827-95, O141, type
H; O, 834-95, O141, type I. Lanes A and P are 1-kb molecular size
standards.
|
|
None of the environmental O141 isolates showed ribotypes identical to
types demonstrated by clinical strains. With the exception of
strain 574-94, the CT-negative O141 strains showed ribotypes which differed from the ribotypes observed among the clinical O141
strains by several fragments. The CT-positive strain 3176-78, recovered
from a water sample in the United States, showed ribotype E, which
demonstrated a 9.5-kb fragment not shown by any of the CT-positive
clinical O141 strains, whereas ribotypes of both O1 and O139 reference
strains demonstrated the 9.5-kb fragment. Although they had a common
9.5-kb fragment, the ribotypes of strain 3176-78, O1 strains, and O139
strains differed by several fragments (Fig. 2)
Southern blot hybridization with the CT probe of
BglI-digested genomic DNAs of the O141 strains showed six
different genotypes consisting of two or three fragments of between 6.8 and 25 kb (results not shown). Each of the strains tested showed
a common 7.1-kb fragment which was also found in the two
V. cholerae O1 reference strains. Little
correspondence was found between ribotype and CT genotype, as
strains with an identical ribotype most often showed different CT
genotypes (Table 1).
 |
DISCUSSION |
In this study, we report sporadic cases of gastroenteritis
associated with V. cholerae serogroup O141. We sought
to further define the virulence-associated gene content of the O141
strains. Specifically, we hoped to address (i) whether clinical O141
strains possessed the same critical virulence genes as O1 and O139
strains, (ii) whether environmental O141 strains were similar to or
distinct from these clinical isolates in terms of their virulence gene content, and (iii) whether ribotyping could be used to establish the
relatedness of O141 strains to each other as well as other V. cholerae serogroups. Of particular importance for
understanding the emergence of toxigenic O141 strains was their TCP
status, given the role of this pilus colonization factor as the
receptor for the CTX phage (44). We found that all
clinical O141 isolates contained TCP genes and at least one copy of the
CTX prophage, based on their reactivity to tcpA,
ctx, zot, and RS1 probes. In contrast,
all but one of the environmental O141 isolates were negative for
ctx, zot, RS1, and tcpA.
The single environmental O141 isolate from Louisiana that was positive
for tcpA was also ctx positive. Ribotyping
confirmed that all CT- and TCP-positive O141 strains were closely
related regardless of their geographical origin, while all
environmental O141 strains were diverse and largely unrelated to each
other or to O1, O139, or O141 clinical isolates. In general, these data
support a model for emergence of toxigenic O141 that involves first the
acquisition of the pathogenicity island encoding TCP followed by the
acquisition of the CTX phage (37, 44). Our data suggest
that once toxigenic O141 emerged, these strains spread regionally as
clones rather than emerging independently in diverse geographic
locations from resident nontoxigenic O141 environmental strains.
Our conclusions appear to be consistent with data from recent studies
addressing similar questions. For example, Faruque et al.
(17) found that only O1 and O139 strains and none of 132 non-O1, non-O139 strains tested carried TCP genes. Similarly, Sharma et
al. (40) reported that of 18 CT-negative strains of non-O1, non-O139 V. cholerae isolated from several
outbreaks in India in 1996, none were positive for TCP genes.
Accordingly, we think that a TCP-positive, CTX-negative O141 strain was
the most likely precursor of the toxigenic O141 strains characterized here. Unfortunately, we could not identify an environmental O141 isolate that was TCP positive or that even displayed a ribotype indistinguishable from or closely related to those of the toxigenic O141 strains. However, clonally related, TCP-positive, CT-negative V. cholerae O1 strains have been documented as
environmental isolates from the Gulf Coast of the United States, and
these strains are clearly closely related to toxigenic strains isolated
from water and clinical samples from the region prior to 1991 (36). Echeverria et al. (14) also reported
that non-O1, non-O139 strains that are TCP positive and CT negative can
be isolated from environmental sources. Thus, TCP-positive
V. cholerae strains, regardless of serogroup, remain
potential precursors of epidemic strains because of their dual capacity
to serve as efficient recipients of CTX phage (particularly in vivo)
and to colonize the human intestine by TCP-dependent mechanisms.
Nonetheless, it is possible that toxigenic O141 strains emerged by
acquisition of the CTX phage first, followed by the TCP island. A few
TCP-negative, CT-positive strains were identified by Faruque et al.
(17), but these strains can be explained by either loss of
the TCP island after CTX phage acquisition or acquisition of the CTX
phage by a TCP-independent mechanism. TCP-independent acquisition of
CTX phage has been reported by Boyd and Waldor (4) and by
Faruque et al. (18). However, these mechanisms involved
generalized transduction by another lytic phage and a far less
efficient undefined mechanism, respectively.
How V. cholerae strains acquire the pathogenicity
island that encodes TCP remains controversial. A recent report by
Karaolis et al. (24) concluded that the pathogenicity
island corresponded to the genome of a filamentous bacteriophage termed
VPI phage which putatively could move between El Tor O1 strains and at
least one recipient strain of the O10 serogroup. However, bioinformatic analysis of the open reading frames (ORFs) present in the island has
failed to uncover genes that have significant homology to phage
assembly genes (20). Nonetheless, the G+C content of the island together with other DNA composition and codon usage analyses supports the conclusion that this island has an origin other than V. cholerae (20, 23). Thus, it is likely
that the TCP genes have been recently acquired by V. cholerae O1, but we cannot say how this has occurred or whether
this mechanism informs us further about the likely evolutionary steps
that lead to the emergence of toxigenic TCP-positive O141 strains.
Previous studies have proposed that when and if horizontal transfer of
TCP and the CTX genetic elements occur, it may be linked to concomitant
changes in the somatic antigen (40). However, our
findings, together with the report by Echeverria et al.
(15) of non-O1, non-O139 environmental strains containing
tcpA and the CTX element, suggest that horizontal transfer
of the O antigen does not necessarily occur before or after the
acquisition of the TCP and CT genes.
In this study we used ribotyping as a phylogenetic tool for accessing
the baseline similarity between the O141 strains in our collection.
Ribotyping using BglI demonstrated indistinguishable or
closely related ribotypes among the O141 strains isolated from stool
specimens. The loss or gain of a BglI restriction site may result in the loss of a fragment and the creation of two new fragments; thus, the minor differences in fragment patterns shown by the clinical
strains suggest that they originated from the same clone. That genetic
events responsible for changes in ribotypes and pulsed-field gel
electrophoresis types are occurring over time was demonstrated by
Dalsgaard et al. (13), who found several closely related V. cholerae O1 ribotypes among strains isolated in
Lima, Peru, during a 5-year period following the introduction of
V. cholerae O1 into Peru in 1991. The close
relationship of toxigenic O141 strains to each other is further
supported by the fact that all these strains lack sequences that
hybridize to the cryptic plasmid pTLC. All toxigenic O1 and O139
strains tested to date possess this integrated plasmid
(36). Thus, together with our ribotyping results, the
absence of pTLC in toxigenic O141 strains strongly suggests that these
strains did not emerge as an O-antigen recombinant of an O1 or O139 strain.
It is difficult to explain how V. cholerae O141 strains
isolated from stool specimens of different geographical and
chronological origins apparently belong to the same clone. Although the
patient data are limited, there is nothing to suggest that the patients in the United States, Spain, and India were epidemiologically related.
The toxigenic O141 strains could be disseminated by cargo chips, e.g.,
contaminated ballast, bilge, and/or sewage, a mode of transmission
which has been described for toxigenic O1 strains from the Latin
American epidemic into the United States (28). It is
uncertain if the toxigenic O141 strain 3176-78, isolated from a water
sample in Louisiana in 1978, could have been the source strain from
which the toxigenic U.S. clinical strains emerged. It is possible that
the differences in ribotype patterns between strain 3176-78 and the
clinical strains may have evolved during the
6-year time span between
their isolation. However, it is most interesting that an O141 strain
containing the CTX phage and TCP was isolated from a U.S. Gulf Coast
water sample in 1978. The U.S. Gulf Coast continues to constitute a
permissive environmental site for persistence of a unique clone of
V. cholerae that includes both
TCP+ nontoxigenic and TCP+
toxigenic strains of V. cholerae O1 (36).
It is tempting to speculate that TCP and perhaps CT might contribute to
the fitness of V. cholerae in some aquatic
environments. If so, toxigenic O141 strains might persist and expand
globally in incidence once virulent strains have emerged. It will be
interesting to determine more precisely the intimate relationships in
which V. cholerae persists within the aquatic
environment and how these influence the fitness of pathogenic versus
nonpathogenic strains or other interactions important for emergence,
such as interaction between the bacterium and its converting phages
(16, 44).
All serogroup O141 strains tested possessed the gene encoding the
regulatory protein ToxR, which controls the coordinate expression of
genes associated with pathogenicity in toxigenic V. cholerae and the 17-bp attRS1 target sequence, in which
the CTX phage integrates into the chromosome of V. cholerae (16). A study of V. cholerae non-O1, non-O139 strains associated with an upsurge in the incidence of
cholera-like diarrhea in Calcutta, India, reported similar findings
with all strains containing toxR and attRS1 genes
(40) and proposed that such non-O1, non-O139 strains could
be proto-cholera agents. Although this may be true, the relative risk
of these strains becoming positive for both TCP and CT genes seems
lower than that of strains that are already positive for TCP and thus can acquire CTX phage by simple transduction. With the few exceptions noted above, most V. cholerae strains that carry CT
genes also carry TCP genes (17). Two explanations have
been proposed to explain why TCP-positive and CT-negative strains are
rarely found (17). One reason may be that such strains do
not cause full-blown cholera and hence are not adequately enriched
through the explosive replication within the human host that fully
virulent strains enjoy. Alternatively, most TCP-positive strains are
rapidly converted to toxigenic strains by infection with CTX phage
either within the host intestine or in the aquatic environment
(15). Given that we were unable to identify any O141
strains that were TCP positive but CT negative, our results do not
differentiate between these two explanations. More curious is why
toxigenic O141 strains have not yet caused a serious cholera epidemic.
Our genetic analysis of these strains suggest that they have this
potential especially in areas of the world where immunity to the O1 and
O139 serogroups provides a selective edge for a heterologous serogroup
such as O141.
V. cholerae non-O1, non-O139 serotypes are increasingly
isolated from patients with diarrhea. Dalsgaard et al. (8)
found that non-O1, non-O139 strains were isolated at rates similar to or higher than those of serotype O1 strains in a study conducted in
Thailand from 1993 to 1995. Such single cases of diarrhea seem most
often to be associated with a wide range of serotypes (8, 40). However, outbreaks of diarrhea have been associated with certain serotypes, e.g., O10 and O12 strains in 1994 in Peru
(6), O6 and O14 strains among Khmers in a refugee camp in
Thailand (1), and O10 strains in India (38).
The non-O1, non-O139 strains from both single and outbreak cases very
rarely contain the tcp and the CTX genetic elements, and
although a number of studies have proposed several potential virulence
factors among non-O1, non-O139 strains, the factor(s) responsible for
diarrhea and its mode of action remain to be identified. With the
recent finding by Lin et al. (26) that the RTX genes
encode a product that has cytotoxic activity for mammalian cells, it
was proposed that the RTX toxin may play an important role in the
virulence of CTX-negative strains. All O141 strains tested in this
study possessed the RTX genes, including several CTX-negative strains isolated from water samples. Preliminary results from ongoing studies
in our laboratories corroborate the findings that a very high
proportion of both environmental and clinical non-O1, non-O139 strain
contain RTX genes (unpublished results). Thus, it appears that the
cytotoxic activity showed by RTX-positive strains may be a widely
distributed virulence factor among V. cholerae non-O1, non-O139 strains.
 |
ACKNOWLEDGMENTS |
We are grateful for the technical assistance provided by
Anne-Mette Petersen at the Royal Veterinary and Agricultural University in Denmark. We also thank the state health departments for providing information about patients and V. cholerae strains.
Anders Dalsgaard was supported by the Danish Council for Development
Research, Danida grant 90928. The laboratory of John J. Mekalanos was
supported by grant AI-18045 from the National Institute of Allergy and
Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary Microbiology, The Royal Veterinary and Agricultural
University, Stigböjlen 4, 1870 Frederiksberg C, Denmark. Phone:
45-35-282720. Fax: 45-35-282757. E-mail: ad{at}kvl.dk.
 |
REFERENCES |
| 1.
|
Bagchi, K.,
P. Echeverria,
J. D. Arthur,
O. Sethabutr,
O. Serichantalergs, and C. W. Hoge.
1993.
Epidemic of diarrhea caused by Vibrio cholerae non-O1 that produced heat-stable toxin among Khmers in a camp in Thailand.
J. Clin. Microbiol.
31:1315-1317[Abstract/Free Full Text].
|
| 2.
|
Baudry, B. A.,
A. Fasano,
J. Ketley, and J. B. Kaper.
1992.
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae.
Infect. Immun.
60:428-434[Abstract/Free Full Text].
|
| 3.
|
Bhattacharya, M. K.,
D. Dutta,
S. K. Bhattacharya,
A. Deb,
A. K. Mukhopadhyay,
G. B. Nair,
T. Shimada,
Y. Takeda,
A. Chowdhury, and D. Mahalanabis.
1998.
Association of a disease approximating cholera caused by Vibrio cholerae of serogroups other than O1 and O139.
Epidemiol. Infect.
120:1-5[CrossRef][Medline].
|
| 4.
|
Boyd, E. F., and M. K. Waldor.
1999.
Alternative mechanism of cholera toxin acquisition by Vibrio cholerae: generalized transduction of CTX by bacteriophage CP-T1.
Infect. Immun.
67:5898-5905[Abstract/Free Full Text].
|
| 5.
|
Braun, V.,
R. Schonherr, and S. Hobbie.
1993.
Enterobacterial hemolysins: activation, secretion and pore formation.
Trends Microbiol.
1:211-216[CrossRef][Medline].
|
| 6.
|
Dalsgaard, A.,
M. J. Albert,
D. N. Taylor,
T. Shimada,
R. Meza,
O. Serichantalergs, and P. Echeverria.
1995.
Characterization of Vibrio cholerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru.
J. Clin. Microbiol.
33:2715-2722[Abstract].
|
| 7.
|
Dalsgaard, A.,
P. Echeverria,
J. L. Larsen,
R. Siebeling,
O. Serichantalergs, and H. H. Huss.
1995.
Application of ribotyping for differentiating Vibrio cholerae non-O1 isolates from shrimp farms in Thailand.
Appl. Environ. Microbiol.
61:245-251[Abstract].
|
| 8.
|
Dalsgaard, A.,
A. Forslund,
L. Bodhidatta,
O. Serichantalergs,
C. Pitarangsi,
L. Pang,
T. Shimada, and P. Echeverria.
1999.
A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes.
Epidemiol. Infect.
122:217-226[CrossRef][Medline].
|
| 9.
|
Dalsgaard, A.,
A. Forslund,
H. F. Mortensen, and T. Shimada.
1998.
Ribotypes of clinical Vibrio cholerae non-O1 non-O139 strains in relation to O-serotypes.
Epidemiol. Infect.
121:535-545[CrossRef][Medline].
|
| 10.
|
Dalsgaard, A.,
H. H. Huss,
A. H- Kittikun, and J. L. Larsen.
1995.
The prevalence of Vibrio cholerae and Salmonella in a major shrimp production area in Thailand.
Int. J. Food Microbiol.
28:101-113[CrossRef][Medline].
|
| 11.
|
Dalsgaard, A.,
O. Serichantalergs,
A. Forslund,
C. Pitarangsi, and P. Echeverria.
1998.
Phenotypic and molecular characterization of Vibrio cholerae O1 isolated in Samutsakorn, Thailand before, during and after the emergence of V. cholerae O139.
Epidemiol. Infect.
121:259-268[CrossRef][Medline].
|
| 12.
|
Dalsgaard, A.,
M. N. Skov,
O. Serichantalergs, and P. Echeverria.
1996.
Comparison of pulsed-field gel electrophoresis and ribotyping for subtyping of Vibrio cholerae O139 isolated in Thailand.
Epidemiol. Infect.
117:51-58[Medline].
|
| 13.
|
Dalsgaard, A.,
M. N. Skov,
O. Serichantalergs,
P. Echeverria,
R. Meza, and D. N. Taylor.
1997.
Molecular evolution of Vibrio cholerae O1 isolated in Lima, Peru, from 1991 to 1995.
J. Clin. Microbiol.
35:1151-1156[Abstract].
|
| 14.
|
Echeverria, P.,
B. A. Harrison,
C. Tirapat, and A. McFarland.
1983.
Flies as a source of enteric pathogens in a rural village in Thailand.
Appl. Environ. Microbiol.
46:32-36[Abstract/Free Full Text].
|
| 15.
|
Echeverria, P.,
C. W. Hoge,
L. Bodhidatta,
O. Serichantalergs,
A. Dalsgaard,
B. Eampokalap,
J. Perrault,
G. Pazzaglia,
P. O'Hanley, and C. English.
1995.
Molecular characterization of Vibrio cholerae O139 isolates from Asia.
Am. J. Trop. Med. Hyg.
52:124-127.
|
| 16.
|
Faruque, S. M.,
M. J. Albert, and J. J. Mekalanos.
1998.
Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.
Microbiol. Mol. Biol. Rev.
62:1301-1314[Abstract/Free Full Text].
|
| 17.
|
Faruque, S. M.,
Asadulghani,
M. N. Saha,
A. R. M. Abdul Alim,
M. J. Albert,
K. M. Nasirul Islam, and J. J. Mekalanos.
1998.
Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTX phage: molecular basis for origination of new strains with epidemic potential.
Infect. Immun.
66:5819-5825[Abstract/Free Full Text].
|
| 18.
|
Faruque, S. M.,
M. M. Rahman,
K. M. Asadulghani,
N. Islam, and J. J. Mekalanos.
1999.
Lysogenic conversion of environmental Vibrio mimicus strains by CTXPhi.
Infect. Immun.
67:5723-5729[Abstract/Free Full Text].
|
| 19.
|
Fesano, A.,
B. Baudry,
A. W. Pumplin,
S. S. Wassermann,
B. D. Tall,
J. M. Ketley, and J. B. Kaper.
1991.
Vibrio cholerae produces a second enterotoxin which affects intestinal tight junctions.
Proc. Natl. Acad. Sci. USA
88:5242-5246[Abstract/Free Full Text].
|
| 20.
|
Heidelberg, J. F.,
J. A. Elsen,
W. C. Nelson, et al.
2000.
DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae.
Nature
406:477-484[CrossRef][Medline].
|
| 21.
|
Honda, T., and T. Iida.
1993.
The pathogenicity of Vibrio parahaemolyticus and the role of the thermostable direct haemolysin and related haemolysins.
Rev. Med. Microbiol.
4:106-113.
|
| 22.
|
Kado, C. I., and S. T. Liu.
1981.
Rapid procedure for detection and isolation of large and small plasmids.
J. Bacteriol.
145:1365-1373[Abstract/Free Full Text].
|
| 23.
|
Karaolis, D. K. R.,
J. A. Johnson,
C. C. Bailey,
E. C. Boedeker,
J. B. Kaper, and P. R. Reeves.
1998.
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.
Proc. Natl. Acad. Sci. USA
95:3134-3149[Abstract/Free Full Text].
|
| 24.
|
Karaolis, D. K. R.,
S. Somara,
D. R. J. Maneval,
J. A. Johnson, and J. B. Kaper.
1999.
A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria.
Nature
399:375-379[CrossRef][Medline].
|
| 25.
|
Kovach, M. E.,
M. D. Shaffer, and K. M. Peterson.
1996.
A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae.
Microbiology
142:2165-2174[Abstract].
|
| 26.
|
Lin, W.,
K. Fullner,
R. Clayton,
J. Sexton,
M. Rogers,
K. Calia,
S. Calderwood,
C. Fraser, and J. Mekalanos.
1998.
Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage.
In
Proceedings of the U.S./Japan Meeting on Cholera and Enteric Diseases.
|
| 27.
|
Mazel, D.,
B. Dychinco,
V. A. Webb, and J. Davies.
1998.
A distinctive class of integron in the Vibrio cholerae genome.
Science
280:605-608[Abstract/Free Full Text].
|
| 28.
|
McCarthy, S. A., and F. M. Khambaty.
1994.
International dissemination of epidemic Vibrio cholerae by cargo ship ballast and other nonpotable waters.
Appl. Environ. Microbiol.
60:2597-2601[Abstract/Free Full Text].
|
| 29.
|
Mekalanos, J. J.
1983.
Duplication and amplification of toxin genes in Vibrio cholerae.
Cell
35:253-263[CrossRef][Medline].
|
| 30.
|
Morris, J. G. J.,
R. Wilson,
B. R. Davis,
I. K. Wachsmuth,
C. F. Riddle,
H. G. Wathen,
R. A. Pollard, and P. A. Blade.
1981.
Non-O group 1 Vibrio cholerae gastroenteritis in the United States.
Ann. Intern. Med.
94:656-658.
|
| 31.
|
National Committee for Clinical Laboratory Standards.
1998.
Performance standards for antimicrobial susceptibility testing. Approved standard M100-S8, vol. 18.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 32.
|
Ogawa, A.,
J. Kato,
H. Watanabe,
B. G. Nair, and T. Takeda.
1990.
Cloning and nucleotide sequence of a heat-stable enterotoxin gene from Vibrio cholerae non-O1 isolated from a patient with traveler's diarrhea.
Infect. Immun.
58:3325-3329[Abstract/Free Full Text].
|
| 33.
|
Olsen, J. E., and J. L. Larsen.
1990.
Restriction fragment length polymorphism of the Vibrio anguillarum serovar O1 virulence plasmid.
Appl. Environ. Microbiol.
56:3130-3132[Abstract/Free Full Text].
|
| 34.
|
Pearson, G. D. N.,
A. Woods,
S. Chaing, and J. J. Mekalanos.
1993.
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.
Proc. Natl. Acad. Sci. USA
90:3750-3754[Abstract/Free Full Text].
|
| 35.
|
Popovic, T.,
C. A. Bopp,
Ö. Olsvik, and K. Wachsmuth.
1993.
Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1.
J. Clin. Microbiol.
31:2474-2482[Abstract/Free Full Text].
|
| 36.
|
Rubin, E. J.,
W. Lin,
J. J. Mekalanos, and M. K. Waldor.
1998.
Replication and integration of a Vibrio cholerae cryptic plasmid linked to the CTX prophage.
Mol. Microbiol.
28:1247-1254[CrossRef][Medline].
|
| 37.
|
Rubin, E. J.,
M. K. Waldor, and J. J. Mekalanos.
1998.
Mobile genetic elements and the evolution of new epidemic strains of V. cholerae, p. 9.x-y.
In
R. M Krause (ed.), Emerging infections. Academic Press, New York, N.Y.
|
| 38.
|
Rudra, S.,
R. Mahajan,
M. Kathur,
K. Kathuria, and V. Talwar.
1996.
Cluster of cases of clinical cholera due to Vibrio cholerae O10 in east Delhi.
Indian J. Med. Res.
103:71-73[Medline].
|
| 39.
|
Sakazaki, R.
1992.
Bacteriology of vibrio and related organisms, p. 37-55.
In
D. Barua, and B. R. Greenough (ed.), Cholera. Plenum Medical Book Company, New York, N.Y.
|
| 40.
|
Sharma, C.,
M. Thungapathra,
A. Ghosh, et al.
1998.
Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.
J. Clin. Microbiol.
36:756-763[Abstract/Free Full Text].
|
| 41.
|
Shaw, C. E., and R. K. Taylor.
1990.
Vibrio cholerae O395 tcpA pilin gene sequence and comparison of predicted protein structural features to those of type 4 pilin.
Infect. Immun.
58:3042-3049[Abstract/Free Full Text].
|
| 42.
|
Shimada, T.,
E. Arakawa,
K. Itoh,
T. Okitsu,
A. Matsushima,
Y. Asai,
S. Yamai,
T. Nakazato,
G. B. Nair,
M. J. Albert, and Y. Takeda.
1994.
Extended serotyping scheme for Vibrio cholerae.
Curr. Microbiol.
28:175-178[CrossRef].
|
| 43.
|
Tabtieng, R.,
S. Wattanasri,
P. Echeverria,
J. Seriwatana,
L. Bodhidatta,
A. Chatkaeomorakot, and B. Rowe.
1989.
An epidemic of V. cholerae El Tor Inaba resistant to several antibiotics with a conjugative group C plasmid coding for type II dihydrofolate reductase in Thailand.
Am. J. Trop. Med. Hyg.
41:680-686.
|
| 44.
|
Waldor, M. K., and J. J. Mekalanos.
1996.
Lysogenic conversion by a filamentous phage encoding cholera toxin.
Science
272:1910-1914[Abstract].
|
| 45.
|
Wright, A. C.,
Y. Guo,
J. A. Johnson,
J. P. Nataro, and J. G. Morris, Jr.
1992.
Development and testing of a non-radioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin.
J. Clin. Microbiol.
30:2302-2306[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, November 2001, p. 4086-4092, Vol. 39, No. 11
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.4086-4092.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Prochazkova, K., Satchell, K. J. F.
(2008). Structure-Function Analysis of Inositol Hexakisphosphate-induced Autoprocessing of the Vibrio cholerae Multifunctional Autoprocessing RTX Toxin. J. Biol. Chem.
283: 23656-23664
[Abstract]
[Full Text]
-
Satchell, K. J. F.
(2007). MARTX, Multifunctional Autoprocessing Repeats-in-Toxin Toxins. Infect. Immun.
75: 5079-5084
[Full Text]
-
Coburn, B., Sekirov, I., Finlay, B. B.
(2007). Type III Secretion Systems and Disease. Clin. Microbiol. Rev.
20: 535-549
[Abstract]
[Full Text]
-
Cordero, C. L., Sozhamannan, S., Satchell, K. J. F.
(2007). RTX Toxin Actin Cross-Linking Activity in Clinical and Environmental Isolates of Vibrio cholerae. J. Clin. Microbiol.
45: 2289-2292
[Abstract]
[Full Text]
-
Danin-Poleg, Y., Cohen, L. A., Gancz, H., Broza, Y. Y., Goldshmidt, H., Malul, E., Valinsky, L., Lerner, L., Broza, M., Kashi, Y.
(2007). Vibrio cholerae Strain Typing and Phylogeny Study Based on Simple Sequence Repeats. J. Clin. Microbiol.
45: 736-746
[Abstract]
[Full Text]
-
Maiti, D., Das, B., Saha, A., Nandy, R. K., Nair, G. B., Bhadra, R. K.
(2006). Genetic organization of pre-CTX and CTX prophages in the genome of an environmental Vibrio cholerae non-O1, non-O139 strain. Microbiology
152: 3633-3641
[Abstract]
[Full Text]
-
Cordero, C. L., Kudryashov, D. S., Reisler, E., Satchell, K. J. F.
(2006). The Actin Cross-linking Domain of the Vibrio cholerae RTX Toxin Directly Catalyzes the Covalent Cross-linking of Actin. J. Biol. Chem.
281: 32366-32374
[Abstract]
[Full Text]
-
Dodd, S. J., Hurst, M. R. H., Glare, T. R., O'Callaghan, M., Ronson, C. W.
(2006). Occurrence of sep Insecticidal Toxin Complex Genes in Serratia spp. and Yersinia frederiksenii.. Appl. Environ. Microbiol.
72: 6584-6592
[Abstract]
[Full Text]
-
Vora, G. J., Meador, C. E., Bird, M. M., Bopp, C. A., Andreadis, J. D., Stenger, D. A.
(2005). Microarray-based detection of genetic heterogeneity, antimicrobial resistance, and the viable but nonculturable state in human pathogenic Vibrio spp.. Proc. Natl. Acad. Sci. USA
102: 19109-19114
[Abstract]
[Full Text]
-
Dziejman, M., Serruto, D., Tam, V. C., Sturtevant, D., Diraphat, P., Faruque, S. M., Rahman, M. H., Heidelberg, J. F., Decker, J., Li, L., Montgomery, K. T., Grills, G., Kucherlapati, R., Mekalanos, J. J.
(2005). Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc. Natl. Acad. Sci. USA
102: 3465-3470
[Abstract]
[Full Text]
-
O'Shea, Y. A., Reen, F. J., Quirke, A. M., Boyd, E. F.
(2004). Evolutionary Genetic Analysis of the Emergence of Epidemic Vibrio cholerae Isolates on the Basis of Comparative Nucleotide Sequence Analysis and Multilocus Virulence Gene Profiles. J. Clin. Microbiol.
42: 4657-4671
[Abstract]
[Full Text]
-
Sheahan, K.-L., Cordero, C. L., Fullner Satchell, K. J.
(2004). Identification of a domain within the multifunctional Vibrio cholerae RTX toxin that covalently cross-links actin. Proc. Natl. Acad. Sci. USA
101: 9798-9803
[Abstract]
[Full Text]
-
Chen, C.-H., Shimada, T., Elhadi, N., Radu, S., Nishibuchi, M.
(2004). Phenotypic and Genotypic Characteristics and Epidemiological Significance of ctx+ Strains of Vibrio cholerae Isolated from Seafood in Malaysia. Appl. Environ. Microbiol.
70: 1964-1972
[Abstract]
[Full Text]
-
Kotetishvili, M., Stine, O. C., Chen, Y., Kreger, A., Sulakvelidze, A., Sozhamannan, S., Morris, J. G. Jr.
(2003). Multilocus Sequence Typing Has Better Discriminatory Ability for Typing Vibrio cholerae than Does Pulsed-Field Gel Electrophoresis and Provides a Measure of Phylogenetic Relatedness. J. Clin. Microbiol.
41: 2191-2196
[Abstract]
[Full Text]
-
Li, M., Kotetishvili, M., Chen, Y., Sozhamannan, S.
(2003). Comparative Genomic Analyses of the Vibrio Pathogenicity Island and Cholera Toxin Prophage Regions in Nonepidemic Serogroup Strains of Vibrio cholerae. Appl. Environ. Microbiol.
69: 1728-1738
[Abstract]
[Full Text]
-
Nesper, J., Krai{beta}, A., Schild, S., Bla{beta}, J., Klose, K. E., Bockemuhl, J., Reidl, J.
(2002). Comparative and Genetic Analyses of the Putative Vibrio cholerae Lipopolysaccharide Core Oligosaccharide Biosynthesis (wav) Gene Cluster. Infect. Immun.
70: 2419-2433
[Abstract]
[Full Text]